BilZ0r
Bluelight Crew
- Joined
- Dec 15, 2003
- Messages
- 6,675
LSD Receptor Affinities
The affinity of LSD for various receptors. The black line represents the lowest affinity LSD could have for that receptors and that effect still being relavant. i.e. Any receptor which has affinities over the bar is not significantly affected by LSD during recreational usage*. I don't know off the top of my head which of those effects are agonisms and which are antagonisms, though I'd be keen for someone to do that dredging.
I put this together to explain LSDs high activity (though could this just be because it is resistant to metabolism? Anyone?) I doubt 5-HT6 has much to do with it, because it seems to be localized heavily in the basal ganglia. 5-HT5 is a possibility thought...
*This conclusion is made from the belief that LSD doesn't reach much above 20nM in the plasma in recreational use, and does not distribute specifically to the brain.
Data from:
PDSP
AGHAJANIAN, G.K. & BING, O.H. (1964). Persistence of Lysergic Acid Diethylamide in the Plasma of Human Subjects. Clin Pharmacol Ther, 10, 611-4.
HAWKS, R.L. & CHIANG, C.N. (1986). Urine Testing for Drugs of Abuse. Rockville, MD: Department of Health and Human Services.

The affinity of LSD for various receptors. The black line represents the lowest affinity LSD could have for that receptors and that effect still being relavant. i.e. Any receptor which has affinities over the bar is not significantly affected by LSD during recreational usage*. I don't know off the top of my head which of those effects are agonisms and which are antagonisms, though I'd be keen for someone to do that dredging.
I put this together to explain LSDs high activity (though could this just be because it is resistant to metabolism? Anyone?) I doubt 5-HT6 has much to do with it, because it seems to be localized heavily in the basal ganglia. 5-HT5 is a possibility thought...
*This conclusion is made from the belief that LSD doesn't reach much above 20nM in the plasma in recreational use, and does not distribute specifically to the brain.
Data from:
PDSP
AGHAJANIAN, G.K. & BING, O.H. (1964). Persistence of Lysergic Acid Diethylamide in the Plasma of Human Subjects. Clin Pharmacol Ther, 10, 611-4.
HAWKS, R.L. & CHIANG, C.N. (1986). Urine Testing for Drugs of Abuse. Rockville, MD: Department of Health and Human Services.
Last edited: